- Home
- ZYXI vs ACCS Comparison
ZYXI vs ACCS Comparison
Compare ZYXI & ACCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- ACCS
- Stock Information
- Founded
- ZYXI 1996
- ACCS 1988
- Country
- ZYXI United States
- ACCS United States
- Employees
- ZYXI N/A
- ACCS N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ACCS Publishing
- Sector
- ZYXI Health Care
- ACCS Consumer Discretionary
- Exchange
- ZYXI Nasdaq
- ACCS Nasdaq
- Market Cap
- ZYXI 44.8M
- ACCS 42.6M
- IPO Year
- ZYXI N/A
- ACCS N/A
- Fundamental
- Price
- ZYXI $1.47
- ACCS N/A
- Analyst Decision
- ZYXI Hold
- ACCS Strong Buy
- Analyst Count
- ZYXI 3
- ACCS 1
- Target Price
- ZYXI $3.00
- ACCS $14.00
- AVG Volume (30 Days)
- ZYXI 84.4K
- ACCS 5.6K
- Earning Date
- ZYXI 10-23-2025
- ACCS 11-06-2025
- Dividend Yield
- ZYXI N/A
- ACCS N/A
- EPS Growth
- ZYXI N/A
- ACCS N/A
- EPS
- ZYXI N/A
- ACCS N/A
- Revenue
- ZYXI $144,808,000.00
- ACCS $22,562,000.00
- Revenue This Year
- ZYXI N/A
- ACCS $0.03
- Revenue Next Year
- ZYXI $7.07
- ACCS $11.45
- P/E Ratio
- ZYXI N/A
- ACCS N/A
- Revenue Growth
- ZYXI N/A
- ACCS 26.44
- 52 Week Low
- ZYXI $1.23
- ACCS $7.79
- 52 Week High
- ZYXI $9.42
- ACCS $13.35
- Technical
- Relative Strength Index (RSI)
- ZYXI 42.64
- ACCS 42.43
- Support Level
- ZYXI $1.42
- ACCS $10.49
- Resistance Level
- ZYXI $1.61
- ACCS $10.90
- Average True Range (ATR)
- ZYXI 0.06
- ACCS 0.50
- MACD
- ZYXI 0.01
- ACCS 0.01
- Stochastic Oscillator
- ZYXI 25.38
- ACCS 62.13
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About ACCS ACCESS Newswire Inc.
ACCESS Newswire Inc is a Public Relations (PR) and Investor Relations (IR) solutions provider. The group focuses on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands.